Research focus

The lab of Medical Biochemistry studies peptidases for the development of new drugs. Main points of interest are the carboxypeptidases, prolyl carboxypeptidase (PRCP), carboxypeptidase U (CPU) and carboxypeptidase M (CPM); the prolyl oligopeptidase (PREP); and the prolyl-specific dipeptidyl peptidases (DPPs), DPP4, DPP8 and DPP9. 


Publications in the spotlight

DPP8/DPP9 inhibition elicits canonical Nlrp1b inflammasome hallmarks in murine macrophages
Vasconcelos Nathalia M.   Vliegen Gwendolyn   Gonçalves Amanda   De Hert Emilie   Martín-Pérez Rosa   Van Opdenbosch Nina   Jallapally Anvesh   Geiss-Frielander Ruth   Lambeir Anne-Marie   Augustyns Koen   van der Veken Pieter   De Meester Ingrid   Lamkanfi Mohamed  
Life science alliance - ISSN 2575-1077-2:1 (2019)

CD26/DPP4 : a potential biomarker and target for cancer therapy
Enz Njanja   Vliegen Gwendolyn   De Meester Ingrid   Jungraithmayr Wolfgang  
Pharmacology and therapeutics - ISSN 0163-7258- (2019) p. 1-110


Contact

Medical Biochemistry Campus Drie Eiken - Building S
D.S.514
Universiteitsplein 1
B-2610 Wilrijk
Belgium
Tel. +32 3 265 27 27
[email protected]

Farmaceutische, Biomedische en Diergeneeskundige Wetenschappen - UAntwerpen